← Back to Search

Procedure

Dry Needling for Knee Pain

N/A
Waitlist Available
Led By Matthew S Briggs, DPT, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up complete immediately before, and immediately after dry needling procedure.
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if knee pain & dry needling affects how the brain perceives pain & left-right body part discrimination in 60 people aged 18-40 with knee pain.

Who is the study for?
This trial is for people aged 18-40 with chronic knee pain, divided into groups based on their fear of movement. One group has high fear (Tampa Scale >37), one has low fear (Tampa Scale <37), and a control group without knee pain. Participants should not have had recent knee surgery, be pregnant, or have neurological issues affecting movement.
What is being tested?
The study tests if dry needling can improve brain perception related to pain and body part discrimination in those with bilateral knee pain. It involves baseline testing using an app and muscle function analysis, followed by dry needling treatment, then retesting—all within a single two-hour session.
What are the potential side effects?
Dry needling may cause some discomfort at the needle site, minor bleeding or bruising, temporary soreness in the muscles treated, or fatigue after the procedure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~complete immediately before, and immediately after dry needling procedure.
This trial's timeline: 3 weeks for screening, Varies for treatment, and complete immediately before, and immediately after dry needling procedure. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Accuracy and response time from left right judgement task
Secondary study objectives
2D Video Assessment of Movement Patterns During Lateral step down test.
Muscle depth of of vastus medialis oblique muscle as measured by Lumify US unit

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Bilateral Patellofemoral Pain with Low Fear of MovementExperimental Treatment1 Intervention
The second group with consist of 20 subjects with bilateral chronic anterior knee pain and low fear of movement between ages of 18 and 40 years old.
Group II: Bilateral Patellofemoral Pain with Fear of MovementExperimental Treatment1 Intervention
The first group will consist of 20 subjects presenting with bilateral chronic anterior knee pain and high fear of movement with scores on Tampa Kinesiophobia Scale (fear of movement) greater than 37.
Group III: Healthy controls without knee painActive Control1 Intervention
The third group will consist of healthy controls without knee pain between 18 and 40 years old.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dry needling
2017
N/A
~1100

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
871 Previous Clinical Trials
655,402 Total Patients Enrolled
1 Trials studying Patellofemoral Pain Syndrome
120 Patients Enrolled for Patellofemoral Pain Syndrome
Matthew S Briggs, DPT, PhDPrincipal InvestigatorThe Ohio State University Wexner Medical Center
1 Previous Clinical Trials
120 Total Patients Enrolled
1 Trials studying Patellofemoral Pain Syndrome
120 Patients Enrolled for Patellofemoral Pain Syndrome

Media Library

Dry Needling (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05976269 — N/A
Patellofemoral Pain Syndrome Research Study Groups: Bilateral Patellofemoral Pain with Fear of Movement, Bilateral Patellofemoral Pain with Low Fear of Movement, Healthy controls without knee pain
Patellofemoral Pain Syndrome Clinical Trial 2023: Dry Needling Highlights & Side Effects. Trial Name: NCT05976269 — N/A
Dry Needling (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05976269 — N/A
~26 spots leftby Jul 2028